Department of Pediatric Cardiac Surgery, Bambino Gesù Children's Hospital, Piazza Sant'Onofrio 4, 00165 Rome, Italy.
Nat Rev Nephrol. 2011 Apr;7(4):218-25. doi: 10.1038/nrneph.2011.15. Epub 2011 Mar 1.
Sepsis is the most common and severe cause of morbidity and mortality among critically ill patients. Multiple organ dysfunction syndrome often complicates sepsis, leading to a worse prognosis that is proportional to the severity and number of damaged organs. Acute kidney injury (AKI) also complicates sepsis, with a linear relationship between the severity of kidney damage and sepsis prognosis. The management of sepsis and septic AKI involves intensive proactive preventive measures, medical and extracorporeal treatment of established sepsis, support of failing organs and rehabilitation of the residual effects left by this devastating syndrome. Unfortunately, although some innovations in the clinical management of sepsis are now available, their beneficial effects on renal function are still uncertain. The aim of this Review is to provide an update on the current state of interventions in sepsis-related AKI. Prevention, pharmacological support and extracorporeal blood purification for septic AKI will be reviewed and discussed.
脓毒症是危重病患者发病率和死亡率最高的常见原因。多器官功能障碍综合征常并发脓毒症,导致预后更差,与器官损伤的严重程度和数量成正比。急性肾损伤(AKI)也会并发脓毒症,肾损伤的严重程度与脓毒症的预后呈线性关系。脓毒症和脓毒性 AKI 的治疗包括积极主动的强化预防措施、对已确诊脓毒症的药物和体外治疗、对衰竭器官的支持以及对这种破坏性综合征遗留的残余影响的康复。不幸的是,尽管脓毒症的临床管理方面现在有了一些创新,但它们对肾功能的有益影响仍然不确定。本综述旨在提供脓毒症相关 AKI 干预措施的最新情况。本文将对脓毒性 AKI 的预防、药物支持和体外血液净化进行回顾和讨论。